Literature DB >> 20066393

[Konzept Perioperative management for endoprosthetic hip joint replacement. The functional interdisciplinary therapy (FIT) concept].

J Jerosch1, J Heisel.   

Abstract

During the last decade there have been significant changes in the perioperative management of total hip replacement patients. This process begins in the preoperative phase. Many patients are much better informed and standardized preoperative patient programs improve patient outcome and optimize the clinical pathways. The techniques in perioperative pain management have also significantly improved. The surgeon should not only rely on the anesthesiologist but should also use the options available during surgery. Postoperative weight bearing is handled in a much more progressive way than previously. In a standard primary hip replacement pain-adapted full weight bearing is possible if there are no patient-specific problems. There has also been a shift in the postoperative capability of performing athletic or recreational activities. In general patients can perform those activities that were performed before the surgery, which also includes, for example downhill skiing.

Entities:  

Mesh:

Year:  2010        PMID: 20066393     DOI: 10.1007/s00113-009-1718-7

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  20 in total

1.  Preoperative quadriceps strength predicts functional ability one year after total knee arthroplasty.

Authors:  Ryan L Mizner; Stephanie C Petterson; Jennifer E Stevens; Michael J Axe; Lynn Snyder-Mackler
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

Review 2.  Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials.

Authors:  Spencer S Liu; Jeffrey M Richman; Richard C Thirlby; Christopher L Wu
Journal:  J Am Coll Surg       Date:  2006-10-25       Impact factor: 6.113

3.  High-dose local infiltration analgesia after hip and knee replacement--what is it, why does it work, and what are the future challenges?

Authors:  Tord Röstlund; Henrik Kehlet
Journal:  Acta Orthop       Date:  2007-04       Impact factor: 3.717

4.  Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee arthroplasty.

Authors:  Paul T Diamond; Mark R Conaway; Samir H Mody; Kiran Bhirangi
Journal:  J Arthroplasty       Date:  2006-08       Impact factor: 4.757

5.  The effect of partial or full weight bearing ambulation after cementless total hip arthroplasty.

Authors:  Steven T Woolson; Neil S Adler
Journal:  J Arthroplasty       Date:  2002-10       Impact factor: 4.757

6.  Patient-controlled analgesia after arthroscopic rotator cuff repair: subacromial catheter versus intravenous injection.

Authors:  Nam Su Cho; Jeong Han Ha; Yong Girl Rhee
Journal:  Am J Sports Med       Date:  2006-08-21       Impact factor: 6.202

7.  The effectiveness of an anesthetic continuous-infusion device on postoperative pain control.

Authors:  F Alan Barber; Morley A Herbert
Journal:  Arthroscopy       Date:  2002-01       Impact factor: 4.772

8.  Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial.

Authors:  Constant A Busch; Benjamin J Shore; Rakesh Bhandari; Su Ganapathy; Steven J MacDonald; Robert B Bourne; Cecil H Rorabeck; Richard W McCalden
Journal:  J Bone Joint Surg Am       Date:  2006-05       Impact factor: 5.284

9.  No adverse effects of early weight bearing after uncemented total hip arthroplasty: a randomized study of 20 patients.

Authors:  Henrik Bodén; Per Adolphson
Journal:  Acta Orthop Scand       Date:  2004-02

Review 10.  Pre-emptive analgesia: performing a painless total knee arthroplasty.

Authors:  Peter J Brooks
Journal:  Orthopedics       Date:  2003-09       Impact factor: 1.390

View more
  1 in total

1.  [Postoperative management of hip and knee endoprostheses].

Authors:  S Seitz; W Rüther
Journal:  Z Rheumatol       Date:  2012-10       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.